Candesartan vs Tofacitinib

## Candesartan vs Tofacitinib: Overview

This comparison examines the pharmacological differences between **Candesartan** and **Tofacitinib**.

## Mechanism of Action

**Candesartan**: Prodrug hydrolyzed to active form; selective angiotensin II type 1 receptor blocker.

**Tofacitinib**: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

## Pharmacokinetics

**Half-life**: Candesartan — 9 hours; Tofacitinib — 3.2 hours.

## Chemical Properties

**Molecular Formula**: Candesartan — C33H34N6O6; Tofacitinib — C16H20N6O.

**Molecular Weight**: Candesartan — 610.6640 g/mol; Tofacitinib — 312.3700 g/mol.

**Type**: Candesartan — Small molecule; Tofacitinib — Small molecule.